The University of Chicago Header Logo

Connection

Mark Lingen to Biomarkers, Tumor

Back to Details
This is a "connection" page, showing publications Mark Lingen has written about Biomarkers, Tumor.
Mark Lingen
Connection Strength
2.090
Biomarkers, Tumor
  1. Biological and Molecular Biomarkers in Oral Potentially Malignant Disorders and Oral Cavity Squamous Cell Carcinoma-Innovation and Insights. Dent Clin North Am. 2025 Jul; 69(3S):e1-e33.
    View in: PubMed
    Score: 0.487
  2. CD34 and a smooth muscle actin distinguish verrucous hyperplasia from verrucous carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014 Apr; 117(4):477-82.
    View in: PubMed
    Score: 0.212
  3. Screening for oral premalignancy and cancer: what platform and which biomarkers? Cancer Prev Res (Phila). 2010 Sep; 3(9):1056-9.
    View in: PubMed
    Score: 0.169
  4. Tissue microarray - a high-throughput molecular analysis in head and neck cancer. J Oral Pathol Med. 2008 Mar; 37(3):166-76.
    View in: PubMed
    Score: 0.142
  5. Application of liquid biopsy as multi-functional biomarkers in head and neck cancer. Br J Cancer. 2022 02; 126(3):361-370.
    View in: PubMed
    Score: 0.092
  6. Overexpression of p53 in squamous cell carcinoma of the tongue in young patients with no known risk factors is not associated with mutations in exons 5-9. Head Neck. 2000 Jul; 22(4):328-35.
    View in: PubMed
    Score: 0.083
  7. Metastatic HPV-Associated Oropharyngeal Versus Primary Pulmonary Squamous Cell Carcinoma: is p16 Immunostain Useful? Head Neck Pathol. 2020 Dec; 14(4):966-973.
    View in: PubMed
    Score: 0.082
  8. Mucoepidermoid Carcinoma: A Comparison of Histologic Grading Systems and Relationship to MAML2 Rearrangement and Prognosis. Am J Surg Pathol. 2019 07; 43(7):885-897.
    View in: PubMed
    Score: 0.078
  9. Molecular markers associated with development and progression of potentially premalignant oral epithelial lesions: Current knowledge and future implications. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018 06; 125(6):650-669.
    View in: PubMed
    Score: 0.071
  10. Met Receptor Tyrosine Kinase and Chemoprevention of Oral Cancer. J Natl Cancer Inst. 2018 03 01; 110(3).
    View in: PubMed
    Score: 0.071
  11. Expression of Hormone Receptors and HER-2 in Benign and Malignant Salivary Gland Tumors. Head Neck Pathol. 2018 Mar; 12(1):95-104.
    View in: PubMed
    Score: 0.068
  12. Involvement of calprotectin (S100A8/A9) in molecular pathways associated with HNSCC. Oncotarget. 2016 Mar 22; 7(12):14029-47.
    View in: PubMed
    Score: 0.062
  13. Quantitative proteomic analysis of microdissected oral epithelium for cancer biomarker discovery. Oral Oncol. 2015 Nov; 51(11):1011-1019.
    View in: PubMed
    Score: 0.060
  14. Critical role for the receptor tyrosine kinase EPHB4 in esophageal cancers. Cancer Res. 2013 Jan 01; 73(1):184-94.
    View in: PubMed
    Score: 0.049
  15. Validation of methods for oropharyngeal cancer HPV status determination in US cooperative group trials. Am J Surg Pathol. 2012 Jul; 36(7):945-54.
    View in: PubMed
    Score: 0.048
  16. Time-dependent transcriptional profiling links gene expression to mitogen-activated protein kinase kinase 4 (MKK4)-mediated suppression of omental metastatic colonization. Clin Exp Metastasis. 2012 Jun; 29(5):397-408.
    View in: PubMed
    Score: 0.047
  17. Prevalidation of salivary biomarkers for oral cancer detection. Cancer Epidemiol Biomarkers Prev. 2012 Apr; 21(4):664-72.
    View in: PubMed
    Score: 0.047
  18. Genetics/epigenetics of oral premalignancy: current status and future research. Oral Dis. 2011 Apr; 17 Suppl 1:7-22.
    View in: PubMed
    Score: 0.044
  19. Plasminogen activator inhibitor-2: a molecular biomarker for head and neck cancer progression. Cancer Res. 2003 Feb 01; 63(3):555-9.
    View in: PubMed
    Score: 0.025
  20. Prospective study evaluating dynamic changes of cell-free HPV DNA in locoregional viral-associated oropharyngeal cancer treated with induction chemotherapy and response-adaptive treatment. BMC Cancer. 2022 Jan 03; 22(1):17.
    View in: PubMed
    Score: 0.023
  21. Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesions. Cochrane Database Syst Rev. 2021 07 20; 7:CD010276.
    View in: PubMed
    Score: 0.022
  22. Ultrasensitive detection of tumor-specific mutations in saliva of patients with oral cavity squamous cell carcinoma. Cancer. 2021 05 15; 127(10):1576-1589.
    View in: PubMed
    Score: 0.022
  23. The Utility of MDM2 and CDK4 Immunohistochemistry and MDM2 FISH in Craniofacial Osteosarcoma. Head Neck Pathol. 2020 Dec; 14(4):889-898.
    View in: PubMed
    Score: 0.020
  24. Plasmacytoid cells in salivary pleomorphic adenoma: an alternative interpretation of their immunohistochemical characteristics highlights function and capability for epithelial-mesenchymal transition. Oral Surg Oral Med Oral Pathol Oral Radiol. 2019 Nov; 128(5):515-529.
    View in: PubMed
    Score: 0.019
  25. Histological features and prognostic significance of treatment effect in lymph node metastasis in head and neck squamous cell carcinoma. Histopathology. 2019 Jan; 74(2):321-331.
    View in: PubMed
    Score: 0.019
  26. Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesions. Cochrane Database Syst Rev. 2015 May 29; (5):CD010276.
    View in: PubMed
    Score: 0.015
  27. Is GATA3 expression maintained in regional metastases?: a study of paired primary and metastatic urothelial carcinomas. Am J Surg Pathol. 2013 Dec; 37(12):1876-81.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.